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Staphylococcus aureusStaphylococcus aureus remains a leading, virulent pathogen capable of expressing complex drug resistance that
requires up to 2–4 days for laboratory analysis. In this study, we evaluate the ability of automated microscopy
of immobilized live bacterial cells to differentiate susceptible fromnon-susceptible responses of S. aureus isolates
(MRSA/MSSA, clindamycin resistance/susceptibility and VSSA/hVISA/VISA) to an antibiotic based on the charac-
terization of as few as 10 growing clones after 4 h of growth, compared to overnight growth required for tradi-
tional culture based methods. Isolates included 131 characterized CDC isolates, 3 clinical isolates and reference
strains. MRSA phenotype testing used 1 h of 1 μg/mL cefoxitin induction followed by 3 h of 6 μg/mL cefoxitin.
Clindamycin susceptibility testing used 1 h of induction by 0.1 μg/mL erythromycin followed by 3 h of 0.5 μg/
mL clindamycin. An automated microscopy system acquired time-lapse dark-ﬁeld images, and then computed
growth data for individual immobilized progenitor cells and their progeny clones while exposed to different
test conditions. Results were compared to concurrent cefoxitin disk diffusion and D-test references. For CDC or-
ganisms, microscopy detected 77/77 MRSA phenotypes and 54/54 MSSA phenotypes, plus 53/56 clindamycin-
resistant and 75/75 clindamycin susceptible strains. Automated microscopy was used to characterize heteroge-
neous and inducible resistance, and perform population analysis proﬁles. Microscopy-based hVISA population
analysis proﬁles (PAPs) were included as an extended proof of concept, and successfully differentiated VSSA
from hVISA and VISA phenotypes compared to plate-based PAP.
© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY license. 1. Introduction
Staphylococcus aureus is a leading cause of serious infection in both
the hospital and the community (Landrum et al., 2012; Klevens et al.,
2007). Methicillin-resistant S. aureus (MRSA) has evolved as a leading
cause of nosocomial infections worldwide and has also emerged as
a major resistance phenotype in community-acquired infections
(Chambers and Deleo, 2009). MRSA strains inherently resist essentially
all β-lactam antibiotics, which make up the largest, most effective, and
most widely used class of antibiotics. Clinical MRSA strains are frequent-
ly multi-drug resistant (MDR) and may express numerous virulenceywere previously presented in
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. Open access under CC BY license. factors (Skrupky et al., 2009), making staphylococcal infections increas-
ingly difﬁcult to treat. S. aureus canhave additional types of antibiotic re-
sistance including resistance to clindamycin and reduced susceptibility
to vancomycin.
Antimicrobial susceptibility testing (AST) is essential to assure ap-
propriate antibiotic choice in treating infection, but typically requires
2–4 days to produce results. Guidelines (Muscedere et al., 2008; Liu
et al., 2011) recommend starting empiric broad-spectrum antibiotic
therapy within 1–3 h of the time that a critically ill patient exhibits
signs of a potentially severe infection. Because of widespread antibiotic
resistance, the patient is thus at risk of receiving inadequate therapy
during the wait for laboratory results (Ibrahim et al., 2000; Iregui
et al., 2002).
Automatedmicroscopy of immobilized individual live bacterial cells is
an innovative rapid phenotypingmethod for AST that analyzes the prop-
erties of a small number of cells to infer the phenotypic response of an en-
tire population in hours compared to overnight culturing methods. The
ﬁrst purpose of this study is to evaluate the performance of automated
microscopy to detect the MRSA phenotype and clindamycin resistance
using induction-based assays on small numbers of cells compared to con-
ventional AST conﬁrmatory methods. Secondly, the ability of the auto-
mated microscopy method to characterize heteroresistant and inducible
51C.S. Price et al. / Journal of Microbiological Methods 98 (2014) 50–58strainswas evaluated, including the time necessary to reveal a phenotyp-
ic response as well as the minimum number of cells required. As an
extended proof of principle, a microscopy-based population analysis
proﬁle (PAP) to differentiate heterogeneous vancomycin intermediate
S. aureus (hVISA) and VISA strains from vancomycin susceptible
S. aureus (VSSA) was evaluated, as this is the best-known use of PAP
currently.
2. Materials and methods
2.1. S. aureus isolates
S. aureus isolates included quality control strains speciﬁed by the CLSI
for the purposes of susceptibility testing (CLSI, 2009): ATCC® 43300
MRSA, ATCC 29213 and 27659 methicillin susceptible S. aureus (MSSA),
BAA-977 clindamycin (CLI) inducible resistance, BAA-976 CLI suscepti-
ble, Mu50/ATCC 700699 VISA, andMu3/ATCC 700698 hVISA (ATCC, Ma-
nassas, VA). The Washington University School of Medicine (St. Louis,
MO) Barnes-Jewish Hospital provided three S. aureus clinical isolates
(1-3C, 1-4C, and 1-6I) that showed growth on 3 μg/mL vancomycin
screening agar. The United States Centers for Disease Control and Pre-
vention (CDC, Atlanta, GA) provided 131 characterized S. aureus isolates
that expressed borderline oxacillin resistance and contained 78 mecA
positive strains and 53 mecA negative strains (Swenson et al., 2007).
Thirty-eight of the CDC strains were D-test positive for inducible CLI re-
sistance, 18 strains expressed constitutive CLI resistance, and 75 strains
were CLI susceptible (Table 1).
Each strain was recovered from −80 °C frozen storage and sub-
cultured on sheep's blood agar (Becton Dickinson, Sparks, MD). Five to
ten colonies selected from a fresh overnight subculture plate were
suspended by vortexing in tryptic soy broth (Becton Dickinson) and in-
cubated for 2 h at 35 ± 2 °C to achieve log phase growth. The bacterial
suspension was centrifuged (12,000 × g for 4 min), washed in 1 mM
L-histidine buffer at a pH of 7.2, and resuspended in a low ionic strength
electrokinetic buffer containing 10 mM L-DOPA and 1 mM L-histidine
at a pH of 7.0 (Accelerate Diagnostics, Tucson, AZ) to create an inoculum
of approximately 1 × 106 CFU/mL.
2.2. Bacterial immobilization
Automatedmicroscopy tests were performed in a custom disposable
multichannel ﬂuidic cassette containing 32 independent ﬂuidic chan-
nels, with each channel having its own independent inlet and outlet
ports for ﬂuid exchange by pipetting (Fig. 1). Each ﬂuidic channel
consisted of a rectangular conduit formed by a die-cut double-adhesive
polyester mask approximately 300 μm thick enclosed by transparent
top and bottom covers. The top cover was also polyester, while the bot-
tom cover consisted of a standard 1 × 3 inch glass microscope slide. The
top and bottom surfaces of each ﬂuidic channel had a transparent, elec-
trically conductive coating of indium tin oxide. The bottom surface had
an additional coating of poly-L-lysine. Bacteria were negatively-charged
in the electrokinetic buffer.
After pipetting 20–30 μL of bacterial inoculum into each indepen-
dent ﬂuidic channel, a 5-min low voltage electrical ﬁeld applied acrossTable 1
Characteristics of CDC S. aureus isolates.
mecA status Cefoxitin disk
diffusion result
D-test result
MRSA MSSA cCLI-Ra iCLI-Rb CLI-Sc
n = 131 78 positive 77 1 17 27 34
53 negative 0 53 1 11 41
a cCLI-R = constitutive clindamycin resistance.
b iCLI-R = inducible clindamycin resistance.
c CLI-S = clindamycin susceptible.the two indium tin oxide layers concentrated individual cells in a ran-
dom dispersion on the bottom surface. After the current was stopped,
the negatively-charged cells remained adherent to the poly-cationic
poly-L-lysine layer through electrostatic binding. This allowed the oper-
ator to pipette test solutions into each ﬂuidic channel to replace the
electrokinetic buffer without detaching the cells. All antibiotic test solu-
tions were prepared using cation-adjusted Mueller–Hinton broth
(Becton Dickinson).
2.3. Automated microscopy
Immobilized bacteria were viewed using a custom microscopy in-
strument (Accelerate Diagnostics Inc., Tucson, AZ) that consisted of an
assembly with an inverted IX-71 microscope (Olympus America, Inc.,
Center Valley, PA) adapted with commercially available accessories
and a 20 × 0.45 NA objective lens that viewed each ﬂuidic channel
from below. Transmitted dark-ﬁeld illumination was generated using a
halogen light source (Olympus). A 12-bit monochrome MicroFire
camera (Olympus) with a 1600 × 1200 pixel frame size captured
dark-ﬁeld time-lapse images in each ﬂuidic channel at 10-min intervals
over the antibiotic exposure period. Each ﬁeld of view covered an area of
592 × 444 μm2 and the observation zone accommodated up to 42 ﬁelds
of view per ﬂuidic channel (Fig. 1). A PC running custom experiment
control software (Accelerate Diagnostics) executed all automated opera-
tions. An XY stage (Prior Scientiﬁc, Cambridge, UK) driven by stepper
motors enabled cassette scanning for synchronous image acquisition. A
heated enclosure maintained the entire instrument setup at 35 ± 2 °C.
2.4. Image analysis
Once collected, the dark-ﬁeld image sequences were analyzed
ofﬂine using custom image analysis software (Accelerate Diagnostics).
The software assigned unique individual spatial XY coordinates to
each immobilized progenitor cell within each ﬂuidic channel. As each
progenitor cell grew into a clone of daughter cells, the assigned coordi-
nates enabled the software to locate each individual growing clone
throughout a series of time-lapse images. The software measured each
clone's intensity as a metric of clone mass in each image. Analysis algo-
rithms calculated a growth probability score for each growing clone
derived from coefﬁcients of a cubic polynomial ﬁtted to a plot of the nat-
ural log of the clone mass vs. time. The growth probability score trans-
formed the shape of each curve into a numerical score ranging
between 0 and 1 that represented the probability of the clone continu-
ing to grow, to arrest, or to lose mass (lyse). The slope of the cubic poly-
nomial was used to calculate instantaneous division rates for individual
clones at speciﬁed time points. For AST classiﬁcation, a growth analysis
algorithm multiplied the growth probability for each clone by its 4 h
endpoint integrated intensity (which is proportional to total cell count
at 4 h) and summed for all clones. This weighted growth probability
was then divided by the summed intensity of all clones to derive an
AST probability score for each isolate.
2.5. MRSA phenotype detection
Triplicate automated microscopy runs were performed on 131 CDC
borderline isolates for MRSA phenotype detection. For each test, a sepa-
rate growth control channel contained the same growth mediumwith-
out any drug. A second channel used 1 μg/mL cefoxitin for 1 h of
induction followed by 3 h of challenge with 6 μg/mL cefoxitin. A third
channel used drug-free medium for 1 h of growth followed by 3 h of
challenge with 6 μg/mL cefoxitin (no induction) as a reference to assess
the magnitude of induction effects. A fourth channel used 1 μg/mL
cefoxitin for 1 h followed by 3 h in drug-free medium as a control. Im-
ages were obtained every 10 min for the 3 h challenge period. AST
probability scores above or below the criterion level of 0.4 classiﬁed
an isolate as MRSA or MSSA, respectively. Concurrent standard CLSI
Fig. 1.Diagram of 32-channel cassette showing detail of individual ﬂuidic channel andmicroscope ﬁelds of view. Fluid exchange occurs using pipette inﬂow and outﬂowports, and image
capture is performed by an inverted microscope positioned beneath the bottom surface of the ﬂuidic channel.
Reprinted from Diagnostic microbiology and infectious disease, S. Metzger, R.A. Frobel, W.M. Dunne, Jr., Rapid simultaneous identiﬁcation and quantitation of Staphylococcus aureus and
Pseudomonas aeruginosa directly from bronchoalveolar lavage specimens using automated microscopy, in press. Copyright 2012, with permission from Elsevier.
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Fig. 2. Performance characteristics of automated microscopy MRSA phenotype test com-
pared to cefoxitin (FOX) disk diffusion for 131 CDC S. aureus isolates. Automated micros-
copy classiﬁcations are based on growth probability values from triplicate runs
(MRSA ≥ 0.4 N MSSA). PPV = positive predictive value; NPV = negative predictive
value.
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ology (Howden et al., 2010).
2.6. Clindamycin resistance detection
Triplicate automated microscopy runs were performed on 131 CDC
borderline isolates to characterize clindamycin resistance. For each
test, a separate growth control channel contained the same growthme-
diumwithout any drug. A second channel used 0.1 μg/mL erythromycin
for 1 h of induction followed by 3 h of challenge with 0.5 μg/mL
clindamycin (Weisblum et al., 1971). A third channel used drug-free
medium for 1 h of growth followed by 3 h of challenge with 0.5 μg/mL
clindamycin (no induction) as a reference to assess themagnitude of in-
duction effects. A fourth channel used 0.1 μg/mL erythromycin for 1 h
followed by 3 h in drug-freemedium as a control. Imageswere obtained
every 10 min for the 3 h challenge period. AST probability scores above
or below the criterion level of 0.4 classiﬁed an isolate as clindamycin re-
sistant or susceptible, respectively. Concurrent standard CLSI disk ap-
proximation induction testing with erythromycin and clindamycin
disks (D-test) was used as the reference for both inducible and constitu-
tive resistance (Howden et al., 2010).
2.7. Characterization of heterogeneous MRSA
Instantaneous division rates at 30, 90 and 180 minwere calculated for
all individual clones for CDC isolates BS-001 (MSSA), BS-006 (MRSA) and
BS-067 (MRSA) in 6 μg/mL cefoxitin channels with 1 μg/mL cefoxitin in-
duction step. Individual clonal division rateswere plotted to generate his-
tograms of individual clonal responses.
2.8. Characterization of inducible MRSA and clindamycin resistance
Instantaneous division rates were calculated for all individual clones
for CDC isolates BS-002 (MSSA), BS-006 (MRSA) and BS-023 (inducible
MRSA) in 6 μg/mL cefoxitin channels with and without 1 μg/mL
cefoxitin induction step to test for inducible resistance to cefoxitin. In-
stantaneous division rates were calculated for all individual clones forCDC isolates BS-042 (clindamycin susceptible), BS-051 (constitutive
clindamycin resistance), and BS-071 (inducible clindamycin resistance)
in 0.5 μg/mL clindamycin channels with and without 0.1 μg/mL eryth-
romycin induction step to test for inducible resistance to clindamycin.
Average clonal division rates for each isolate were plotted vs. time to
generate growth curves for comparison.
2.9. Minimum clone simulation
A computer simulation randomly picked 1, 3, 5, 10, 25 or 50 clones
from each MRSA phenotype or clindamycin resistance test run and cal-
culated the resulting average growthprobability for each set of triplicate
runs for each isolate. These valueswere used to calculate sensitivity and
speciﬁcity for each isolate based on each number of clones.
2.10. Population analysis proﬁle (PAP) by automated microscopy and
plating
Six isolates (Mu50, Mu3, 1-6I, 1-4C, BS-003 and 1-3C) with vanco-
mycin MICs ranging from 0.5 to 8 μg/mL were selected for PAP. For au-
tomated microscopy-based PAP, each isolate was placed in ten ﬂuidic
channels. Molten 0.85% agar (Becton Dickinson) at 42 °C was added to
growthmedium containing the following concentrations of vancomycin
Fig. 3. Scatter plot comparingMRSA phenotype classiﬁcation results for 131 CDC S. aureus
isolates generated by automated microscopy and cefoxitin (FOX) disk diffusion. Growth
probabilities are the average from triplicate automated microscopy runs.
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Fig. 5. Performance characteristics of automated microscopy clindamycin resistance test
compared to D-test for 131 CDC S. aureus isolates. Automated microscopy classiﬁcations
are based on growth probability values from triplicate runs (CLI-R ≥ 0.4 N CLI-S). CLI-
R = clindamycin resistant; CLI-S = clindamycin susceptible; PPV = positive predictive
value; NPV = negative predictive value.
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Each concentration of agar/vancomycin medium was introduced into
one of the ten ﬂuidic channels, and solidiﬁed by cooling to ambient tem-
perature (b30 °C) prior to image acquisition. The image analyzer iden-
tiﬁed the number of growing clones that exhibited at least 4-fold gain in
mass over the 4 h analysis period. Computation normalized these
counts by dividing them by the total number of growing clones detect-
ed. These normalized countswere indexed between 0 and 1 and plotted
vs. vancomycin concentration to generate microscopy-based PAPs.
An abbreviated plate-based PAP (Pfeltz et al., 2001) used 10-fold se-
rial isolate concentrations from 1 × 101 to 1 × 108 CFU/mL pipette-
dropped in duplicate onto sectors of agar plates containing 0, 0.25, 0.5,
0.75, 1, 2, 2.5, 3, 4, or 6 μg/mL vancomycin. Colonies were manually
counted after 48 h of growth, and normalized and indexed plate counts
were plotted vs. vancomycin concentration to generate plate-based
PAPs. Area under the curve (AUC) was measured in all tests.2.11. Statistical methods
Comparisons between automated microscopy and culture control
methods for phenotype tests were summarized in 2 × 2 tables with cal-
culations for sensitivity, speciﬁcity and positive and negative predictive
values.Fig. 4. Reproducibility of MRSA phenotype test. Difference from mean of automated mi-
croscopy growth probability values for triplicate runs on 131 CDC S. aureus isolates. Results
separated by MSSA or MRSA phenotype.3. Results
3.1. MRSA detection
Phenotype testing by automated microscopy detected 78/78
(sensitivity = 100%) CDC strains as MRSA and 57/57 (speciﬁcity =
100%) as MSSA, using cefoxitin disk diffusion phenotype testing as the
reference (Figs. 2 & 3). Overall repeatability between tests on individual
isolates was approximately 95% for both MRSA and MSSA strains
(Fig. 4). Five MSSA strains (BS-001, BS-033, BS-036, BS-059 and
BS-097) and one MRSA strain (BS-096) had discordant classiﬁcations
between triplicate runs. Growth probabilities ranged from 0.003 to
0.195 below the cutoff and from 0.423 to 0.985 above the cutoff of 0.4
for the ﬁve MSSA strains. MRSA strain BS-096 had growth probabilities
of 0.031 vs. 0.984 and 0.984 over three runs.
3.2. Clindamycin resistance detection
Automated microscopy classiﬁed 53/56 (sensitivity = 95%) as
clindamycin resistant and 75/75 (speciﬁcity = 100%) CDC strains as
clindamycin susceptible, using the D-test as the reference (Figs. 5 & 6).
100% of constitutive clindamycin resistance strainswere detected as re-
sistant. Two inducible clindamycin resistant strains (BS-069, BS-050)
had all growth probabilities from triplicate runs below the cutoff of
0.4, classifying them as false susceptibles. Inducible clindamycin resis-
tant strain BS-070 had one test result with a growth probability above
the 0.4 cutoff (0.448), while the other two tests produced growth prob-
abilities below the cutoff (0.206 and 0.353), classifying it as a false
susceptible. Two inducible clindamycin resistant strains (BS-027 and
BS-137) and one clindamycin susceptible strain (BS-132) had discor-
dant classiﬁcations between triplicate runs. Strain BS-027 had growth
probabilities of 0.088 vs. 0.928 and 0.895, and strain BS-137 had growthFig. 6. Scatter plot of clindamycin phenotype classiﬁcation results for 131 CDC S. aureus
isolates generated by automated microscopy. Growth probabilities are the average from
triplicate automated microscopy runs.
Fig. 7.Repeatability of clindamycin resistance phenotype test. Difference frommean of au-
tomatedmicroscopy growth probability values for triplicate runs on 131 CDC S. aureus iso-
lates. Results separated by phenotype.
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probabilities of 0.588 vs. 0.198 and 0.269. Overall repeatability between
tests on individual isolates was approximately 95% for susceptible andFig. 8. Frequency distributions of clonal growth rates for S. aureus isolates (a) BS-001
(MSSA), (b) BS-067 (MRSA), and (c) BS-006 (MRSA). Individual clone growth rates in di-
visions per hour (div/h) measured during exposure to 6 μg/mL cefoxitin at 30, 90 and
180 min using automatedmicroscopy are shown. The vertical axis represents the propor-
tion of all clones measured, binned by division rate and smoothed for visualizing changes
at different durations of drug exposure.constitutive resistant strains, and approximately 90% for inducible resis-
tant strains (Fig. 7).
3.3. Heterogeneous MRSA analysis
Population analysis proﬁles of strains BS-001 (MSSA), BS-067
(MRSA) andBS-006 (MRSA) based on instantaneous division rates of in-
dividual clones at 30, 90 and 180 min were generated using automated
microscopy of strains exposed to 6 μg/mL cefoxitin following a 1 h in-
duction step in 1 μg/mL cefoxitin (Fig. 8). 100% of MSSA strain BS-001
clones had division rates N0 after 30 min in 6 μg/mL cefoxitin. Division
rates shifted to the left with prolonged exposure, until 73% of the popu-
lation division rates were b0 after 180 min, indicating susceptibility.
100% of MRSA strain BS-067 clones had division rates N0 after 30 min
in cefoxitin. Division rates also shifted slightly to the leftwith prolonged
exposure. However, 71% of the BS-067 population had division rates N0
after 180 min, indicating resistance. MRSA strain BS-006 had division
rates shift to the right with prolonged exposure and 97% of the popula-
tion division rates were N0 after 180 min, indicating resistance.
3.4. Characterization of inducible MRSA and clindamycin resistance
Growth curves based on the average division rates of all clones in the
strain population for MSSA strain BS-002 and MRSA strains BS-006 and
BS-023 are shown in Fig. 9. MSSA strain BS-002 average division rates
started at ~1.4 div/h and decreased to negative values over 3 h of expo-
sure to 6 μg/mL cefoxitin with andwithout prior inductionwith 1 μg/mL
cefoxitin, indicating susceptibility. MRSA strain BS-006 starting average
division rates decreased slightly from 1.3 div/h to 0.9 div/h after 1 h
of exposure to 1 μg/mL cefoxitin. After 3 h of additional exposure to
6 μg/mL cefoxitin both curves showed ﬁnal division rates ~1.7 div/h,Fig. 9. Growth curves for strains BS-006 (MRSA), BS-023 (inducible MRSA) and BS-002
(MSSA) over 3 h of exposure to 6 μg/mL cefoxitin following 1 h of exposure to (a)
Mueller-Hinton broth or (b) 1 μg/mL cefoxitin. The curves are based on the average divi-
sion rates of all clones in the strain population.
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ducible MRSA strain BS-023 increased from 1.5 to 1.8 div/h upon expo-
sure to 1 μg/mL cefoxitin for 1 h, compared to Mueller–Hinton broth
alone. Without prior induction, average division rates fell to negative
values after 3 h of exposure to 6 μg/mL cefoxitin. When induced with
1 μg/mL cefoxitin, BS-023 exhibited average division rates of ~1.7 div/h
after 3 h of exposure to 6 μg/mL cefoxitin, indicating resistance. Growth
curves for strains exhibiting clindamycin susceptibility (BS-042), consti-
tutive clindamycin resistance (BS-051) and inducible clindamycin resis-
tance (BS-071) based on the average division rates of all clones in the
strain population are shown in Fig. 10. Strain BS-042 starting average di-
vision rates decreased from 0.9 to 0.6 div/h after 1 h of exposure to
0.1 μg/mL erythromycin, indicating erythromycin susceptibility. After
3 h of additional exposure to 0.5 μg/mL clindamycin, BS-042 division
rates decreased to 0.2 div/h independent of prior induction with eryth-
romycin, indicating susceptibility. Strain BS-051 average division rates
started at ~0.9 div/h and increased to ~1.2 div/h after 3 h of exposure
to 0.5 μg/mL clindamycin independent of prior induction with erythro-
mycin, indicating resistance. Average division rates for inducible strain
BS-071 decreased from 1 div/h to 0.2 div/h over 3 h of exposure to
0.5 μg/mL clindamycinwithout prior induction. However, when induced
with 0.1 μg/mL erythromycin, BS-071 average division rates started at
1.8 div/h and decreased to 0.6 div/h indicating higher resistance to
clindamycin after induction than susceptible strain BS-042.
3.5. Minimum clones required for classiﬁcation
MRSA phenotype test results were based on an average total clone
count of 324 ± 133 (range = 28–762) clones per test. ComputerFig. 10. Growth curves for S. aureus strains exhibiting constitutive clindamycin resistance
(BS-051, cCLI-R), induced clindamycin resistance (BS-071, iCLI-R), and clindamycin sus-
ceptibility (BS-042, CLI-S). The curves are based on the average division rates of all clones
in the strain population over 3 h of exposure to 0.5 μg/mL clindamycin following1 h of ex-
posure to (a) Mueller–Hinton broth or (b) 0.1 μg/mL erythromycin.simulation results showed analysis based on 10 or more clones per test
produced 100% sensitivity for MRSA phenotype detection (Fig. 11(a)).
Analysis based on 3 to 5 clones per test produced 99% sensitivity, and
results from 1 clone per test produced 84% sensitivity. For MSSA pheno-
type detection, 100% speciﬁcity was obtained for all numbers of clones.
Clindamycin resistance detection test results were based on an average
total clone count of 224 ± 101 (range = 23–655) clones per test. Com-
puter simulation results showed analysis based on 5 or more clones per
test produced 95% sensitivity (Fig. 11(b)). Analysis of 3 clones per test
produced 96% sensitivity, and analysis of 1 clone per test produced 71%
sensitivity. For clindamycin susceptibility detection, analysis based on
10 or more clones per test produced 100% speciﬁcity. Analysis of 1 to 5
clones per test produced speciﬁcities ranging from 97 to 100%.
3.6. Population analysis proﬁles by automated microscopy and plating
Population analysis proﬁles of isolates Mu50, Mu3, 1-6I, 1-4C,
BS-003 and 1-3C were generated using automated microscopy and
traditional plate-based methods (Fig. 12). Strains 1-3C (vancomycin
MIC = 0.5 μg/mL) and BS-003 (vancomycin MIC = 2 μg/mL) showed
greater susceptibility to vancomycin than hVISA reference strain Mu3
(vancomycin MIC = 3 μg/mL) by both methods (AUCs = 3.1 and 4.4,
respectively, vs. 5.1 for Mu3 by the plate method and AUCs = 5.9 and
6.4, respectively, vs. 6.7 for Mu3 by automated microscopy), classifying
them as VSSA's relative to the Mu3 reference strain. Strain 1-6I (vanco-
mycin MIC = 4 μg/mL) showed greater resistance to vancomycin than
VISA reference strain Mu50 (vancomycin MIC = 8 μg/mL) by both
methods (AUC = 8.0 vs. 5.4 for Mu50 by the plate method and
AUC = 8.6 vs. 7.9 forMu50 by automatedmicroscopy). Although strain
1-4C (vancomycin MIC = 0.5 μg/mL) had greater susceptibility to van-
comycin than Mu3, its area under the curve was greater than 0.9 times
theMu3 area under the curve (4.9 vs. 4.6), classifying it as hVISA by theFig. 11. Sensitivity and speciﬁcity by total number of clones analyzed for (a)MRSA pheno-
type test and (b) clindamycin resistance test. The average growth probabilities of n ran-
domly selected clones from triplicate runs of 131 CDC S. aureus isolates were calculated
to determine the minimum number of clones required to achieve a result. Y-axis is
truncated at 50% to clarify region of difference. CLI-R = clindamycin resistant; CLI-
S = clindamycin susceptible.
Fig. 12. Population analysis proﬁles for S. aureus isolates Mu50 (ATCC-700699), Mu3
(ATCC-700698), 1-6I, 1-4C, BS-003, and 1-3C with vancomycin MICs of 8, 3, 4, 0.5, 2,
and 0.5 μg/mL, respectively, were generated by (a) automated microscopy and (b) tradi-
tional plate-based methods using multiple concentrations of vancomycin ranging from 0
to 4 μg/mL for automated microscopy and 0 to 6 μg/mL for the plate method. Counts
were normalized and indexed between 0 and 1.
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showed greater susceptibility to vancomycin than Mu50, but greater
resistance than Mu3, classifying it as hVISA by automated microscopy
as well. Automated microscopy results were generated from counting
the number of growing clones with a 4-fold increase in mass after 4 h
of exposure to different concentrations of vancomycin. Images of
clone growth in 0 to 4 μg/mL vancomycin at 0, 2 h and 4 h are shown
for hVISA reference strain Mu3 (Fig. 13).4. Discussion
In this study, automated microscopy of immobilized bacterial cells
demonstrated the ability to characterize the responses of individual
progeny clones within a S. aureus sample population. The method was
able to use growth data collected over 4 h from as few as 10 growing
clones to accurately derive the susceptibility of test isolate classiﬁcation
in multiple concurrent antibiotic tests. None of the studied resistant
phenotypes can be reliably performed using direct organism/antibiotic
MIC breakpoints: e.g.methicillin MIC, clindamycin MIC, or vancomycin
MIC (van Hal et al., 2011). These tests therefore presented a stringent
challenge. In addition, the strain collectionused to challenge themicros-
copy MRSA assay speciﬁcally included isolates that expressed border-
line methicillin (oxacillin) susceptibility and resistance. In addition to
these results, automated microscopy showed feasibility for directly de-
tecting and characterizing complex modes of resistance expression in-
cluding heterogeneous response and inducible resistance.MRSA has long been known to express a high degree of
heteroresistance (Tomasz et al., 1991). Automated microscopy showed
clear differences in the distribution of clonal growth rates during
cefoxitin exposure with different isolates (Fig. 8). Strain BS-001
(Fig. 8(a)) had theMSSA phenotype as determined by cefoxitin disk dif-
fusion (25 mm). A strong and steady shift in clonal growth rates oc-
curred, from normal at 30 min (relative to drug-free growth controls)
to lysis (negative growth rate), arrest, or substantially slowed division
rate at 180 min, with 27% of clones having division rates greater than
zero. At the opposite extreme, BS-006 (Fig. 8(c)) appeared to be a
constitutive highly resistant strain (cefoxitin disk zone = 6 mm).
During cefoxitin exposure, there was a slight overall rise in clonal
growth rates from 30 to 180 min, with a broad distribution at the end.
After 180 min, 97% of the BS-006 clone population exhibited division
rates greater than zero. In between, BS-067 appeared to express
heteroresistance (Fig. 8(b), cefoxitin disk zone = 19 mm). Slightly de-
pressed growth rates at 30 min spread broadly through 180 min with
71% of clones continuing to exhibit positive growth rates despite an
overall slowing trend. These results show that automated microscopy
can differentiate MSSA and MRSA isolate phenotypic responses after
just 3 h of growth compared to 18 h required by current broth
microdilution methods.
Another signiﬁcant ﬁnding was direct observation of MRSA induc-
tion, which has also long been recognized (Ubukata et al., 1989). Serial
cefoxitin induction was used to determine whether a signiﬁcant induc-
tion occurred and, if so, how it might affect assay performance. 2/77
MRSA strains exhibited a signiﬁcant induction effect. Fig. 9 shows the
growth curves for constitutive MRSA BS-006, MSSA BS-002, and induc-
ibleMRSA BS-023.Without induction, the BS-023 change in growth rate
during 6 μg/mL cefoxitin exposure closely paralleled that of MSSA BS-
002. Induction for 1 h with 1 μg/mL cefoxitin substantially shifted the
growth curve to closely parallel that of constitutive MRSA BS-006.
Lack of induction could lead to a verymajor error, identifying a strain
as MSSA when in fact it is an inducible MRSA. Although this situation
may rarely occur with conventional AST, a recent research report
(Penn et al., 2013) suggests that it may occur on occasion. Using direct
induction appears to reduce or eliminate this risk. In addition, the strong
result of induction may enable a shorter required test time for reliable
interpretation rather than extending test duration in the hope of self-
induction eventually producing the correct result.
The same rationale andﬁndings apply to inducible clindamycin resis-
tance. Fig. 10 compares the growth curves for constitutive clindamycin
resistance (strain BS-051), inducible resistance (BS-071), and suscepti-
bility (BS-042) with and without 0.1 μg/mL erythromycin induction for
1 h. Without induction, BS-071 would have caused a very major error
under the conditions that were tested.
Finally, automated microscopy differentiated between VSSA, hVISA,
and VISA phenotypes based on accelerated population analysis proﬁles.
The microscopy PAP as with conventional PAP (Hiramatsu et al., 1997)
compared the area under a PAP curve to that of the Mu3 (hVISA) refer-
ence strain. Fig. 12 shows that microscopy PAP results were analogous
to traditional culture results for the same strains.
hVISA strains exhibit vancomycin MICs in the susceptible range and
can be missed by standard MIC-based screening methods (Howden
et al., 2010). For example, hVISA strain 1-4C had a vancomycin MIC of
0.5 μg/mL by broth microdilution. However, population analysis by cul-
ture methods and by automated microscopy both classiﬁed it as hVISA
(Fig. 12). Traditional agar-dilution PAP culture methods are laborious
and require 48 h to produce a result. In this study, traditional agar dilu-
tion PAPs required manual plating of eight isolate dilutions on agar
plates containing ten different concentrations of vancomycin. In con-
trast, automated microscopy required testing with ten different vanco-
mycin concentrations, and data collected during 4 h of growth was
sufﬁcient to achieve a result.
MRSA phenotype results had no discordanceswith the cefoxitin disk
diffusion reference. There was, however, one discrepancy with mecA
Fig. 13.Dark-ﬁeld images of hVISA reference strainMu3 (ATCC 700698) in different vancomycin concentrations (0, 0.4, 1, 2 and 4 μg/mL) at 0, 2 and 4 h. The number of growing clones in
each vancomycin concentration after 4 h was used to generate population analysis proﬁles. Growth was determined by mass increase over time. Images are zoomed in and contrast en-
hanced for visualization in print. Scale bar in the lower right image is 50 μm.
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mance. As noted earlier by Swenson et al. (2007), one strain in the
CDC collection, BS-089, has amutatedmecA as a result. This strain tested
as phenotypically susceptible in the earlier study (cefoxitin disk zone
28 mm, cefoxitin MIC 4 μg/mL, and oxacillin MIC 0.5 μg/mL) and by
cefoxitin disk diffusion in this study. Unlike the earlier study, this
study was not intended to correlate MRSA test results withmecA con-
tent. The ﬁnding in this study supports concerns expressed about gene
detection methods that may miss mutated genes, detect other muta-
tions as afﬁrmative as with BS-089, and detect markers from dead bac-
teria, non-viable bacteria, and cell debris arising from successful
antibiotic treatment (Afshari et al., 2012).
Three inducible clindamycin resistant strains tested with induction
produced growth probability scores in the susceptible range. Further
optimization of the clindamycin resistance assay may be necessary to
improve accuracy.
Computer simulations demonstrated that in this study, classifying
the phenotypic response of a single clone was enough to predict the
response of susceptible isolates, achieving N97% concordance with ref-
erence methods. A minimum of 10 clones, however, was required toreliably predict the response of resistant isolates. This ﬁnding may re-
ﬂect the homogeneous nature of susceptible isolate populations in com-
parison to resistant strains that frequently have subpopulations
exhibiting varying levels of resistance.
The use of previously characterized isolates was a limitation of this
study. Further studies are warranted for testing a broad collection of
clinical isolates, including additional borderline characteristics, and po-
tentially to explore the advantages of direct live-cell extraction and
analysis directly to patient specimens.
In conclusion, automated microscopy of immobilized live bacterial
cells offers an innovation that can infer the response of an isolate or
sample population by using responses fromas few as 10 growing clones.
It differentiates susceptible from non-susceptible phenotypes within a
few hours, and is not confounded by mutations or heterogeneous or in-
ducible resistance phenotypes. In a clinical setting, this method may
allow clinicians to choose the right antibiotic sooner in order to success-
fully treat themost common cause of serious infection presenting to the
healthcare setting. It may also be useful for deciphering increasingly
complex resistance phenotypes that are not always apparent with
current conventional methodology.
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